The Validation Bottleneck for Psychiatric Biomarkers
This Viewpoint outlines the gap between discovery and clinical integration in biomarker research and recommends collaborative steps to translate biomarker research into routine care in psychiatry.
Authors
- Bruno Pedraz‐Petrozzi (ORCID: https://orcid.org/0000-0002-4119-971X)
- Marion Leboyer (ORCID: https://orcid.org/0000-0001-5473-3697)
- Rachel Upthegrove (ORCID: https://orcid.org/0000-0001-8204-5103)
- Husseini K. Manji (ORCID: https://orcid.org/0009-0007-1679-8749)
Institutions
- Inserm (FR)
- Heidelberg University (DE)
- Birmingham and Solihull Mental Health NHS Foundation Trust (GB)
- Oxford Health NHS Foundation Trust (GB)
- Yale University (US)
- University of Oxford (GB)
- Fondation FondaMental (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Central Institute of Mental Health (DE)
- Precision for Medicine (United States) (US)
- Hôpitaux Universitaires Henri-Mondor (FR)
- Institut Mondor de Recherche Biomédicale (FR)
- Medizinische Fakultät Mannheim (DE)
- Deutsches Zentrum für Psychische Gesundheit (DE)
Publication Details
- Journal
- JAMA Psychiatry
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1001/jamapsychiatry.2026.3583
- Primary Topic
- Mental Health and Psychiatry
- Type
- article
- Field-Weighted Citation Impact
- 0.00